AXA names new directors as dividend approved
AXA has appointed two new directors and reappointed Ramon de Oliveira for a four-year term as director. The appointments were approved at its shareholders’ meeting, along with a €1.43 dividend per share for the 2020 fiscal year was approved, to be paid on May 11. AXA also launched the AXA For Progress Index to ensure it fulfils its purpose.
The new directors are Guillaume Faury and Ramon Fernandez. Both will serve a four-year term. The AXA For Progress Index aims to make tangible the group’s purpose, which was presented last year as “Acting for human progress in protecting what matters”.
The AXA For Progress Index aims to measure and amplify the impact of AXA’s purpose on the group’s activities through a set of precise objectives. For investments, these are reduction of the carbon footprint of the general account assets by 20 percent by 2025 and development of the green investment portfolio to reach €25 billion by 2023.
For insurance, the objectives are strengthening the share of insurance products with a positive impact on the environment, through the guarantees or services offered, and promotion of inclusive insurance for vulnerable populations.
For corporate responsibility, the objectives are training all employees on climate issues by 2023 and carbon neutrality of its activities by 2025 by reducing emissions from its operations by 20 percent and offsetting residual emissions.
The AXA For Progress Index will also incorporate AXA's position in the S&P Global Corporate Sustainability Assessment, which recognises the most responsible companies in the financial sector.
Thomas Buberl, CEO of AXA, said: “After defining our purpose, the launch of the AXA For Progress Index is an important step which will allow it to permeate all of our actions. We will also accelerate its deployment by integrating the index’s objectives into our executive compensation criteria. This initiative reinforces our approach of confirming AXA’s responsible commitments towards all its stakeholders.”
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze